Tekmira Pharmaceuticals Conference Call Advisory

2007 Audited Financial Results and New Corporate Announcement

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- 03/28/08 -- Tekmira Pharmaceuticals Corporation ("Tekmira") (TSX: TKM) announced today that it will hold a conference call and webcast on Monday March 31, 2008 at 5:30 am Pacific Time (8:30 am Eastern Time) to discuss the Company's 2007 audited financial results and provide details on a new corporate development at Tekmira.

About the Conference Call

To participate in the conference call, please dial 416-641-6139 or 1-866-299-6657. The call will be available for replay until April 14, 2008 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3257382.

The live or archived webcast can also be accessed through the Company's website at www.tekmirapharm.com.

About Tekmira

Tekmira Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. Further information about Tekmira and this news release can be found at www.tekmirapharm.com.

The common shares of Tekmira are traded on the Toronto Stock Exchange under the trading symbol "TKM".

Contacts: Tekmira Pharmaceuticals Corporation - Investors Ian Mortimer Senior Vice President, Finance and Chief Financial Officer (604) 419-3200 Website: www.tekmirapharm.com

James Hoggan & Associates Inc. - Media Karen Cook (604) 739-7500 Email: kcook@hoggan.com

2008-03-28 21:14:52 0322542 MARKETWIRE